원문정보
초록
영어
Objective: Clinical practice guidelines (CPGs) are systematically developed statements aimed at helping optimal care of the patient in a given clinical circumstance. Because of the increasing evidence that active implementation of CPGs improve health outcomes, there is a growing awareness of the importance of guideline development and dissemination. The objective of this study was to investigate the status of CPG development and availability of the CPGs in Korea. Method: We searched in the Web sites of 180 organizations to identify CPGs which were developed and/or published in Korea until 1 July 2014. The data of titles, published year, publisher, distributer, and accessibility at the internet web of all CPGs were collected and analyzed. Results: A total of 172 CPGs were developed and 80% had been released since 2009. Most (51.2%) were developed for management of 4 diseases: 28 for digestive system disease; 27 for infectious disease; 18 for endocrine and metabolic diseases; and 15 for neoplasms. Of the 172 CPGs, 150 CPGs were publicly available. Among the 150 CPGs, 78.7% (118/150) were developed by only one organization. Conclusion: To ensure the production of high-quality CPGs, it is necessary to collaborate with other relevant professional societies in guideline development process. In addition, stronger efforts on wider dissemination of CPGs must be employed at the country levels to promote implementation of CPGs in clinical settings.
목차
연구 방법
자료수집
자료정리
자료 분석 및 통계처리
연구 결과
국내 임상진료지침의 종류
연도별 임상진료지침의 개발 및 발표 현황
학회 별 임상진료지침의 발표 현황
학회 별 개발한 임상진료지침의 수
회원가입 여부와 무관하게 열람이 가능한 지침서로서 개발 처와게시 처가 동일한 지침서
회원가입 여부와 무관하게 열람이 가능한 지침서로서 개발 처와게시 처가 상이한 지침서
개발 처와 게시 처가 상이한 지침서로서 비 회원으로서 열람이불가능하였던 지침서
해당 학회의 홈페이지에서 개발 및 발표되었음을 밝히고 있으나비 회원으로서 열람이 불가능하였던 지침서
KoMGI에서 개발되었음을 밝히고 있으나 열람이 불가능하였던 지침서
5년 이내 개정 현황
고찰
결론
참고문헌
별첨1. 가이드라인 개발 현황 조사 대상 180개의 학회 및 기관의 목록